Stocks to buy for 2026: Max Healthcare, Amber Enterprises among 4 stocks that could give 20-40% return in 1 year
1/5
Brokerage Recommendations
Brokerages remain constructive on select stocks across healthcare, real estate, manufacturing, and pharmaceuticals, highlighting strong business fundamentals and favourable sector tailwinds.
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:
2/5
Goldman Sachs on Max Healthcare Institute Ltd
Goldman Sachs on Max Healthcare Institute Ltd: Buy| Target Rs 1325| LTP Rs 1048| Potential Upside 26%
Goldman Sachs has maintained a Buy rating on Max Healthcare Institute with a target price of Rs 1,325, implying a 26% upside from the current market price of Rs 1,048.
Goldman Sachs has maintained a Buy rating on Max Healthcare Institute with a target price of Rs 1,325, implying a 26% upside from the current market price of Rs 1,048.
3/5
Motilal Oswal on Aditya Birla Real Estate
Motilal Oswal on Aditya Birla Real Estate: Buy| Target Rs 2275| LTP Rs 1718| Potential Upside 32%
Motilal Oswal has reiterated a Buy call on Aditya Birla Real Estate, setting a target of Rs 2,275, which suggests a 32% potential upside from the current level of Rs 1,718.
Motilal Oswal has reiterated a Buy call on Aditya Birla Real Estate, setting a target of Rs 2,275, which suggests a 32% potential upside from the current level of Rs 1,718.
Amazon Top Deals
POWERED BY
Crompton Ozone 75 Litres Desert Air Cooler for home | Large & Easy Clean Ice Chamber | 4-Way Air Deflection | High Density Honeycomb Pads | Everlast Pump | Auto Fill| 3 Year Brand Warranty
₹9,798Buy Now43%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹18,780Buy Now22%
OFF
4/5
Elara Capital on Amber Enterprises Ltd
Elara Capital on Amber Enterprises Ltd: Buy| Target Rs 8460| LTP Rs 6585| Potential Upside 28%
Elara Capital has maintained a Buy recommendation on Amber Enterprises with a target price of Rs 8,460, indicating a 28% upside from the last traded price of Rs 6,585.
Elara Capital has maintained a Buy recommendation on Amber Enterprises with a target price of Rs 8,460, indicating a 28% upside from the last traded price of Rs 6,585.
5/5
Citi on Divi’s Laboratories Ltd
Citi on Divis Laboratories Ltd: Buy| Target Rs 9140| LTP Rs 6380| Potential Upside 43%
Citi has reaffirmed its Buy rating on Divi’s Laboratories, assigning a target price of Rs 9,140, which translates into a potential upside of 43% from the current market price of Rs 6,380.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
Citi has reaffirmed its Buy rating on Divi’s Laboratories, assigning a target price of Rs 9,140, which translates into a potential upside of 43% from the current market price of Rs 6,380.
(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)